Neocor launches Russia's first bioprosthetic heart valve production plant in Kemerovo

Neocor launches Russia's first bioprosthetic heart valve production plant in Kemerovo

Diagram of a human heart highlighting the valves, labeled with numbers and text to indicate a patent for a heart valve.

Neocor launches Russia's first bioprosthetic heart valve production plant in Kemerovo

Neocor has opened a new bioprosthetic heart valve plant in Kemerovo. The facility marks a major step for the company, allowing it to move from rented spaces to its own production site. Funding for the project reached 346 million rubles, with contributions from multiple sources. The project received financial backing from several institutions. SME Bank provided 80 million rubles for construction, while Russia's Industry Development Fund (IDF) issued a subsidized loan of 90 million rubles. An additional 10 million rubles came from the Kuzbass Industrial Development Fund.

The new plant will significantly boost production capacity. Annual output of bioprosthetic heart valves is set to rise from 2,000 to 4,500 units. Neocor also manufactures annuloplasty rings, cardiovascular patches, and vascular bioprostheses at the site. Neocor's key customers include state and private cardiovascular surgery centres. The company plans to start producing transcatheter heart valves by 2027, expanding its product range further.

The Kemerovo facility strengthens Neocor's position in the medical device market. With increased production and new product lines, the company aims to meet growing demand. The total investment of 346 million rubles supports long-term development in cardiac healthcare.

Neueste Nachrichten